SCHEMBL1806295

SCHEMBL1806295

CC(C)OCc1n[nH]c(-c2ncccc2F)c1C(=O)OC(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
TP53 P04637 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPC1 O15118 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
GLA P06280 1/20 0.32
TSHR P16473 1/20 0.32
KMT2A Q03164 3/20 0.32
TRPV1 Q8NER1 1/20 0.32
WNT1 P04628 1/20 0.32
DYRK1A Q13627 1/20 0.32
KDM4E B2RXH2 1/20 0.32
PARP1 P09874 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1806658 0.81 MAPK1 (0.33) L3MBTL1ALDH1A1MAPK1
SCHEMBL1807572 0.80 CYP1A2 (0.32) PARP1
SCHEMBL1807759 0.77 TDP2 (0.42) MAPTSMN1; SMN2NPC1L3MBTL1KMT2A
SCHEMBL1806943 0.73 TDP2 (0.43) LMNASMN1; SMN2NPC1L3MBTL1KMT2A
SCHEMBL1806318 0.71 PDE4D (0.50) CA12CA1CA2CA7CA9
SCHEMBL1804749 0.69 MAPT (0.45) LMNAMAPTTP53SMN1; SMN2NPC1
SCHEMBL28423158 0.67 MAPT (0.46) CA12CA1CA2CA7CA9
SCHEMBL1803979 0.64 TDP2 (0.43) LMNATP53SMN1; SMN2KMT2AKDM4E
SCHEMBL10921548 0.62 TDP2 (0.42) CA12CA1CA2CA7CA9
SCHEMBL9944381 0.62 NAPRT (0.56) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501703-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS Eli Lilly and Company (US) 2012-09-26 EP disclosed
WO-2011060035-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2011-05-19 WO disclosed